Publications by authors named "Windschall D"

Objectives: To identify an optimal pediatric musculoskeletal ultrasound (MSUS) protocol for the detection of knee arthritis in patients with juvenile idiopathic arthritis (JIA) including a comparison with existing protocols. Secondary aims were to correlate MSUS-identified B-Mode (BM) and Power Doppler-Mode (PD) synovitis with clinical findings.

Methods: Consecutive JIA patients with confirmed knee arthritis after clinical examination underwent a thorough MSUS study protocol which included views identified and consented by the Pediatric Rheumatology european Society (PReS) Imaging Working Party for the detection of synovitis.

View Article and Find Full Text PDF

Background: Regular physical activity (PA) has been proven to help prevent non-communicable diseases and is beneficial for disease management in chronically ill populations. Physical inactivity and recreational screen-based media (SBM) use are related to poor health outcomes and common among youth. This study aimed to (1) investigate PA levels and recreational SBM use of adolescents with JIA over time and (2) compare these behaviours with those of their peers.

View Article and Find Full Text PDF

Objective: To investigate the psychosocial burden in children and adolescents with juvenile rheumatic diseases during the COVID-19 pandemic.

Methods: As part of the multicentre observational KICK-COVID study linked to the National Pediatric Rheumatology Database, adolescents < 21 years and parents of children < 12 years with rheumatic diseases answered questions on perceptions of health risk (PHR) due to SARS-CoV2, stress, well-being (WHO-5) and symptoms of depression (PHQ-9) and anxiety (GAD-7). Data were collected at routine visits from June to December 2021 and assessed for association with demographic and clinical parameters, treatment and patient-reported outcomes by multivariable regression analyses.

View Article and Find Full Text PDF

Background: Previous studies have shown that growing up with rheumatic conditions can fuel dissatisfaction and psychological distress, which in turn affects disease self-management and treatment adherence. Primary objective of this study was to estimate the prevalence of anxiety and depression symptoms in adolescents and young adults (AYA) with juvenile idiopathic arthritis (JIA) and to identify correlates of conspicuous screening results.

Methods: Initiated as part of the COACH multicenter observational study, outpatients aged 12 to 21 years participating in the National Pediatric Rheumatological Database (NPRD) were prospectively screened for mental health using the Patient Health Questionnaire-9 (PHQ-9) and the Generalised Anxiety Disorder Scale-7 (GAD-7).

View Article and Find Full Text PDF

Background: Physical active lifestyles are essential throughout growth and maturation and may offer potential preventive and therapeutic benefit in patients with juvenile idiopathic arthritis (JIA). Insufficient physical activity (PA), in contrast, can lead to aggravation of disease-related symptoms. This study aimed to i) examine PA levels in children and adolescents with JIA compared to general population controls and ii) investigate correlates of pronounced physical inactivity in order to identify risk groups for sedentary behaviour.

View Article and Find Full Text PDF

Introduction: Chronic non-bacterial osteomyelitis (CNO) is an autoinflammatory bone-disease of unknown origin. The National Pediatric Rheumatologic Database (NPRD) collects long-term data of children and adolescents with rheumatic diseases including CNO.

Objective: To assess characteristics, courses, and outcomes of CNO with onset in childhood and adolescence and to identify outcome predictors.

View Article and Find Full Text PDF

Objective: Synovitis and tenosynovitis are present in juvenile idiopathic arthritis (JIA), both as joint pain and/or inflammation, making them difficult to detect on physical examination. Although ultrasonography (US) allows for discrimination of the 2 entities, only definitions and scoring of synovitis in children have been established. This study was undertaken to produce consensus-based US definitions of tenosynovitis in JIA.

View Article and Find Full Text PDF

Objectives: To develop and evaluate German versions of the Parent Adherence Report Questionnaire (PARQ) and Child Adherence Report Questionnaire (CARQ) and to evaluate adherence in patients with juvenile idiopathic arthritis (JIA).

Methods: The PARQ and CARQ were translated into German, cross-culturally adapted and administered to patients (age ≥ 8 years) and their parents enrolled in the Inception Cohort Study of newly diagnosed JIA patients (ICON). The psychometric issues were explored by analyzing their test-retest reliability and construct validity.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the characteristics of inflammatory bowel disease (IBD) in pediatric patients with juvenile idiopathic arthritis (JIA) and aimed to identify potential risk factors.
  • Among 5009 JIA patients analyzed, 28 developed IBD, primarily Crohn's disease, with a recorded incidence rate of 0.56% over 20 years.
  • The findings suggest a higher incidence of IBD in JIA patients compared to the general population, indicate that pretreatment with methotrexate (MTX) may offer protection, and reveal that treatment with etanercept (ETA) does not prevent IBD development.
View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to evaluate how adding methotrexate (MTX) affects the effectiveness, safety, and longevity of biologic treatments for polyarticular juvenile idiopathic arthritis (JIA).
  • - Analysis included 2,148 patients: 1,464 receiving a combination of biologics and MTX, and 684 on biologic monotherapy; results showed significant improvements in disease activity and longer treatment survival for those on combination therapy.
  • - While combination therapy improved treatment outcomes, it was linked to a slight increase in gastrointestinal and liver-related side effects, with serious adverse events being similar in both treatment groups.
View Article and Find Full Text PDF

Objective: Analysis of etanercept biosimilars in pediatric patients with juvenile idiopathic arthritis (JIA) in comparison with the etanercept originator in terms of efficacy and safety.

Methods: Patients diagnosed with JIA who started treatment with either the etanercept originator or a biosimilar after January 1, 2017, were selected from the German BIKER registry (Biologics in Paediatric Rheumatology Registry). Furthermore, patients who started therapy with the originator and switched to a biosimilar during the course of therapy were identified.

View Article and Find Full Text PDF

After simultaneous multiple local treatment with glucocorticoids at 46 sites a 4‑year-old female patient with newly diagnosed polyarticular juvenile idiopathic arthritis (JIA) initially developed Cushing's syndrome followed by a gradual worsening of her condition and finally an acute high fever urinary tract infection. Iatrogenic adrenocortical insufficiency after multiple intra-articular glucocorticoid administration was diagnosed. The possibility of severe systemic glucocorticoid side effects after extensive local treatment should be included in the regular management of JIA patients.

View Article and Find Full Text PDF

Objectives: To determine (i) correlates for etanercept (ETA) discontinuation after achieving an inactive disease and for the subsequent risk of flare and (ii) to analyze the effectiveness of ETA in the re-treatment after a disease flare.

Methods: Data from two ongoing prospective registries, BiKeR and JuMBO, were used for the analysis. Both registries provide individual trajectories of clinical data and outcomes from childhood to adulthood in juvenile idiopathic arthritis (JIA) patients treated with biologic disease-modifying anti-rheumatic drugs (bDMARDs) and conventional synthetic DMARDs (csDMARDs).

View Article and Find Full Text PDF

Objectives: To evaluate healthcare services for patients with juvenile idiopathic arthritis (JIA) from the parent-proxy perspective and to identify factors associated with perceived deficits in care.

Methods: Patients with JIA from 11 paediatric rheumatology units were enrolled in an inception cohort within the first 12 months after diagnosis. Healthcare services were assessed using The Child Healthcare Questionnaire on satisfaction, utilisation and needs.

View Article and Find Full Text PDF
Article Synopsis
  • - Systemic juvenile idiopathic arthritis (sJIA) is driven by immune system issues, particularly related to interleukin-1β (IL-1β), and IL-1 inhibitors have proven effective in treatment, according to data from the German AID-registry.
  • - A study involving 202 patients from 17 centers revealed that 111 children received IL-1 inhibitors (Anakinra or Canakinumab), with many achieving inactive disease or remission in the first year, although some arthritis persisted in polyarticular cases.
  • - The findings suggest a generally positive response to IL-1 inhibitors with tolerable side effects, as only 15% of patients needed to change their medication during treatment and only a
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the risk of common infections, severe adverse events (SAE), and opportunistic infections in juvenile idiopathic arthritis (JIA) patients treated with various biologic therapies, specifically focusing on IL-1, IL-6, TNFα-inhibitors, and Abatacept.
  • A total of 3258 JIA patients were analyzed from the German BIKER registry, revealing that those treated with IL-1 and IL-6 inhibitors had a significantly higher incidence of infections compared to those on TNFα inhibitors.
  • Key risk factors identified included the use of corticosteroids, younger age, existing cardiac issues, and higher JIA disease activity, which could inform clinical decisions and patient management.
View Article and Find Full Text PDF

This article reviews the role of musculoskeletal ultrasound (MSUS) for the diagnosis, monitoring and treat-to-target management of JIA. Technological advancements in MSUS allow more precise evaluation of arthritis, tenosynovitis and enthesitis versus clinical examination alone, which may assist treatment decisions. In adult studies, serum and synovial biomarkers have correlated with MSUS findings.

View Article and Find Full Text PDF

The role of ultrasound imaging in the diagnosis and monitoring of paediatric rheumatic diseases with special emphasis on recent scientific work regarding the evidence base and standardization of this technique is being reviewed. An overview of the most important practical aspects for the use of musculoskeletal ultrasound in a clinical setting is also provided. Huge scientific efforts and advances in recent years illustrate the increasing importance of musculoskeletal ultrasound in pediatric rheumatology.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to create and test a new scoring system for assessing cartilage changes in rheumatoid arthritis (RA) patients using ultrasound.
  • A systematic review and Delphi survey were conducted, followed by web-based and patient exercises where experts scored ultrasound images of finger joints in RA patients.
  • The new semiquantitative scoring system showed excellent reliability for individual readings and good to moderate reliability when comparing scores between different readers, indicating ultrasound's promise in evaluating cartilage changes in RA.
View Article and Find Full Text PDF

Due to maturation of joints, various changes take place, not only in the field of paediatric rheumatology but also in paediatric orthopaedics musculoskeletal ultrasound plays an important role in both the diagnosis and the follow-up of diseases in this field. To differentiate between physiological and pathological findings, the knowledge of reference values of joint structures is indispensable. The objective was to define B-mode ultrasound age- and sex-related reference values for the elbow joint in healthy children and adolescents during maturation.

View Article and Find Full Text PDF

Background: Recently preliminary ultrasonography (US) definitions, in B mode, for normal components of pediatric joints have been developed by the OMERACT US group. The aim of the current study was to include Doppler findings in the evaluation and definition of normal joint features that can be visualized in healthy children at different age groups.

Methods: A multistep approach was used.

View Article and Find Full Text PDF

Unlabelled: Defining of gray scale ultrasound standard reference values of the shoulder joint in childhood and adolescence during maturation.

Patients: We examined 445 healthy girls and boys between 1 year and 18 years of age. A cross-sectional multicentre grey-scale ultrasound study was performed to examine the shoulder joint on both sides.

View Article and Find Full Text PDF

Objective: To determine the intra- and interobserver reliability of ultrasound (US)-detected age-related joint vascularization and ossification grading in healthy children.

Methods: Following standardized image acquisition and machine setting protocols, 10 international US experts examined 4 joints (wrist, second metacarpophalangeal joint, knee, and ankle) in 12 healthy children (divided into 4 age groups: 2-4, 5-8, 9-12, and 13-16 years). Gray-scale was used to detect the ossification grade, and power Doppler ultrasound (PDUS) was used to detect physiologic vascularization.

View Article and Find Full Text PDF